Alternatives to Emendo Biotherapeutics

A biotechnology company developing precision genetic medicines through base editing technology to treat a broad range of diseases.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-powered spatial biology platform for precision medicine and drug development.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Harnessing genetic data for digital insights in rare and germline disorders.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

Transforming healthcare by turning scientific fiction into scientific facts.

Microbiome technology platform for developing novel therapeutics.

Biomedical platform with intelligent search for medical citations and clinical trial recruitment.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

AI-powered multi-omics platform for early breast cancer detection and risk prediction.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Bioinformatics platform for rapid discovery and validation of precision mental health treatments.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Next-generation molecular diagnostics for immediate and accurate pathogen detection anywhere.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Microbiome drug discovery company developing customized phage therapies for chronic diseases.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.

Designs and creates novel enzymes for sustainable and cost-effective bioproduction.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

Therapeutics company developing novel treatments for complex diseases.

Developing novel diagnostics to predict patient response to immunotherapy.

Develops minimally invasive bioelectronic solutions for treating low back pain and spinal degeneration.

Early-stage clinical company developing smart targeted radioligands for precision oncology.

Global life sciences company providing diagnostic and biopharma laboratory services.

Develops AI-powered decision support tools for personalized medical data interpretation and prediction.

Leveraging the adaptive immune system to diagnose and treat disease.

Biotechnology company personalizing medical cannabis treatment using metabolic biomarker analysis.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.

Global leader in enzymatic therapeutics for non-surgical tissue repair, replacing existing standards of care.

Develops an endovascular solution for vasospasm treatment in aneurysmal subarachnoid hemorrhage.

Clinical-stage company developing novel treatments for ocular inflammatory blinding diseases.

Bioz is an AI search engine for life science experimentation, helping scientists find validated and cost-effective products.

A medical platform connecting patients and physicians with genetic expertise.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

AI-powered diagnostic imaging for early detection of diabetic retinopathy.

AI-powered blood analysis for precise substance tracing and classification in healthcare and research.

A global oncology company developing and commercializing innovative cancer treatments.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.